×

Quick Answer / Study Overview:

This study provides an exhaustive breakdown of the United States Federal and Ohio State Research and Development (R&D) Tax Credit frameworks. It highlights the rigorous statutory criteria—such as the Four-Part Test for qualified research—alongside transformative legislative updates like Ohio House Bill 33. Through detailed case studies in Healthcare, Aerospace, Polymer Science, Smart Manufacturing, and Information Technology, the study demonstrates how Cleveland-based businesses can successfully document and claim these powerful incentives to drive localized technological innovation.

The United States Federal R&D Tax Credit Framework

The United States federal Research and Development (R&D) tax credit, formally codified under Internal Revenue Code (IRC) Section 41, was established by the Economic Recovery Tax Act of 1981 to incentivize domestic innovation, technological advancement, and long-term economic growth. The legislative intent behind the credit is to encourage businesses to invest in the research and development of new technologies, products, and processes by lowering the after-tax cost of these investments. The credit allows taxpayers to offset their federal income tax liability based on the incremental amount of qualified research expenditures (QREs) paid or incurred during a taxable year.

The federal credit is inherently incremental, meaning it rewards companies for increasing their R&D spending over a historically established baseline. Taxpayers generally have the option to calculate the credit using the Regular Research Credit (RRC) method or the Alternative Simplified Credit (ASC) method. The RRC utilizes a complex formula involving a fixed-base percentage and the taxpayer’s average annual gross receipts for the four taxable years preceding the credit year. Conversely, the ASC method simplifies the calculation by basing the credit on a percentage of the current year’s QREs that exceed 50% of the average QREs from the three preceding taxable years.

Qualified Research Expenditures (QREs) are strictly defined and generally fall into three primary categories. First, in-house research expenses encompass the W-2 wages paid to employees for the actual conduct of qualified research, as well as the wages paid to those engaging in the direct supervision or direct support of such research activities. Second, the cost of supplies consumed or destroyed during the research process qualifies, provided these supplies are not treated as depreciable assets. The costs of renting computers or utilizing cloud hosting services directly tied to software development or research simulations also fall under this category. Third, 65% of contract research expenses paid to independent, third-party contractors performing qualified research on behalf of the taxpayer may be claimed. Notably, if these amounts are paid to a “qualified research consortium”—defined as a tax-exempt organization under Section 501(c)(3) or 501(c)(6) that is organized and operated primarily to conduct scientific research—the eligible percentage increases to 75%.

For startups and small businesses, IRC Section 41(b)(4) provides a critical exception regarding the traditional “trade or business” requirement. Normally, tax deductions and credits require that expenses be incurred in the active carrying on of an existing trade or business. However, for in-house research expenses, a taxpayer is treated as meeting this requirement if, at the time the expenditures are paid or incurred, the principal purpose of the taxpayer is to use the results of the research in the active conduct of a future trade or business. This provision is instrumental in allowing pre-revenue technology and bioscience startups to capture and carry forward R&D credits during their most cash-intensive development phases.

The Four-Part Test for Qualified Research

To be eligible for the federal R&D tax credit, the research activities must constitute “qualified research.” The Internal Revenue Service (IRS) mandates that the activities pass a rigorous, statutory Four-Part Test outlined in IRC Section 41(d). Every discrete business component—defined as a product, process, computer software, technique, formula, or invention—must independently satisfy all four criteria to be deemed eligible. The failure to meet even a single prong of this test disqualifies the activity and its associated expenditures.

Statutory Requirement Description and Legal Threshold
Section 174 Test (Permitted Purpose) Expenditures must be eligible for treatment as research and experimental expenditures under IRC Section 174. The activities must be intended to discover information that eliminates uncertainty concerning the development or improvement of a business component. Uncertainty exists if the information currently available to the taxpayer does not establish the capability or method for developing or improving the component, or the appropriate design of the component.
Technological in Nature Test The research must be undertaken for the purpose of discovering information that is technological in nature. The process of experimentation must fundamentally rely on principles of the hard sciences, specifically physical sciences, biological sciences, computer science, or engineering. Activities relying on social sciences, arts, or humanities are statutorily excluded.
Business Component Test The application of the discovered information must be intended to be useful in the development of a new or improved business component of the taxpayer. A qualified purpose includes research related to the development of new or improved functions, performance, reliability, or quality. Research related solely to style, taste, cosmetic enhancements, or seasonal design factors does not qualify.
Process of Experimentation Test Substantially all of the activities must constitute elements of a process of experimentation. Courts and regulations have defined “substantially all” as meaning that 80% or more of the taxpayer’s research activities for that component must be dedicated to this process. This involves a systematic process designed to evaluate one or more alternatives to achieve a result where the capability or method is uncertain. Activities must include identifying the uncertainty, identifying alternatives, and conducting a process of evaluating those alternatives through modeling, simulation, or systematic trial and error.

Federal Case Law and IRS Guidance

Interpreting the statutory language of IRC Section 41 requires an exhaustive analysis of federal case law, which provides practical boundaries and operational definitions for the R&D tax credit. The courts have frequently adjudicated disputes regarding what constitutes a true “process of experimentation,” the substantiation of employee wages, the definition of eligible supplies, and the assessment of tax penalties for aggressive claims. These judicial precedents serve as the guiding principles for tax administration and corporate compliance.

Suder v. Commissioner (T.C. Memo. 2014-201)

The Tax Court’s decision in Suder v. Commissioner is a landmark ruling that provides a highly detailed framework for evaluating software and technology companies under the IRC Section 41 standards. Eric Suder, the CEO of Executive Systems Inc. (ESI), claimed extensive federal R&D credits for developing new telephone systems and related telecommunications technology. The IRS aggressively challenged the eligibility of the projects, arguing that they did not meet the stringent process of experimentation test. Furthermore, the IRS contested the adequacy of the company’s documentation and the reasonableness of the multimillion-dollar wages paid to the CEO.

The court ruled heavily in favor of the taxpayer regarding project eligibility, finding that 11 of the 12 sampled projects satisfied the Four-Part Test. The court specifically noted that ESI’s systematic testing, architectural design iterations, and meticulous documentation of efforts to overcome software development uncertainties met the statutory “process of experimentation” requirement. This ruling was pivotal because it affirmed that software development, when conducted systematically to eliminate technical uncertainty, firmly qualifies as technological research. Furthermore, the court praised ESI’s documentation, establishing that contemporaneous time tracking, test logs, and detailed design architectures are sufficient substantiation to defend against an IRS audit.

However, the court ruled against the taxpayer on the critical issue of wage reasonableness. Applying the standards of IRC Section 174, the court found that the CEO’s compensation was grossly excessive relative to his actual, direct R&D contributions and the hours he legitimately spent supervising the research. Consequently, the court drastically reduced the eligible wage amount utilized in the credit calculation, demonstrating that merely holding an executive title does not justify claiming immense salaries as QREs. Because the company and its owners acted in good faith with reasonable cause, relying on documented studies, the court determined that no penalties were warranted.

Union Carbide Corp. v. Commissioner (T.C. Memo. 2009-50, aff’d 2d Cir. 2012)

Union Carbide Corp. v. Commissioner provides critical judicial guidance on the distinction between routine production costs and qualified R&D supplies, as well as establishing the stringent threshold required to prove a scientific process of experimentation. The multinational chemical company attempted to claim the costs of massive quantities of raw chemical supplies used during plant-scale testing at its manufacturing facilities in Hahnville, Louisiana. The core of the dispute lay in the fact that the materials produced during these experimental manufacturing runs were subsequently sold to customers in the ordinary course of business.

The Second Circuit Court of Appeals affirmed the Tax Court’s ruling that only the additional costs of supplies directly tied to the research—not the routine production costs that the company would have incurred regardless of the research being performed—qualify for the R&D credit. The court noted that the legislative purpose of the research tax credit is to encourage companies to spend more on research than they would have otherwise. Allowing credits for all supplies used in routine production simply because a test was running concurrently would create an “unintended windfall” for normal business expenses.

Furthermore, regarding one of the company’s specific initiatives (the sodium borohydride project), the court held that Union Carbide failed the process of experimentation test. The court found that the company did not conduct sufficient post-test analysis or systemic evaluation to resolve the technical uncertainties. The ruling emphasized that mere trial and error, without rigorous scientific analysis, documentation of hypotheses, and systemic evaluation of the results, is insufficient to meet the standard of qualified research under Section 41.

Moore v. Commissioner (T.C. Memo. 2023-20)

In the more recent case of Moore v. Commissioner, the IRS successfully challenged an S corporation’s substantiation of qualified time performed by the company’s president and Chief Operating Officer. Under Treasury Regulations Section 1.41-2(c), qualified services are strictly defined as the “actual conduct of qualified research” (such as a scientist operating in a laboratory), as well as the “direct supervision or direct support” of such research activities.

The court’s ruling in Moore highlighted the critical, absolute necessity of tying specific employee hours to specific, qualified business components. The taxpayers attempted to estimate the executives’ R&D time retrospectively, without providing credible, contemporaneous corroborating evidence. The court found these estimates to be unreliable. This case underscores that high-level estimations of executive time are highly susceptible to disallowance under IRS examination. Taxpayers must produce concrete evidence—such as emails, calendar invites, code commits, technical meeting minutes, or test logs—to substantiate that individuals claiming “direct supervision” were actively engaged in resolving technical uncertainties rather than merely performing high-level administrative or financial oversight.

Little v. Commissioner and the Penalty Framework

Federal tax administration relies heavily on penalties to deter aggressive or fraudulent tax positions. Case law such as Little v. Commissioner (106 F.3d 1445, 9th Cir. 1997) establishes the judicial framework for additions to tax and negligence penalties. The courts have consistently maintained that negligence and substantial understatement additions under former Section 6653(a) and current Section 6662 are designed to deter noncompliance and penalize taxpayers who take unsubstantiated tax positions.

In the context of R&D tax credits, aggressive over-allocations of executive time, claiming non-technological activities, or failing to properly document the process of experimentation can trigger these substantial understatement penalties. The judicial consensus dictates that while taxpayers are expected to consider tax incentives when making investment decisions, they cannot claim benefits without rigorous adherence to the statutory requirements. The imposition of these penalties serves as a financial risk to deter companies from treating the R&D credit as a generalized subsidy rather than a targeted incentive for actual technological advancement.

The Ohio State R&D Investment Tax Credit

In alignment with federal incentives, the State of Ohio offers a highly favorable Research and Development Investment Tax Credit to stimulate local innovation, attract high-technology enterprises, and foster high-paying job creation. Codified under Ohio Revised Code (ORC) Sections 5726.56 and 5751.51, the credit provides a nonrefundable benefit against the state’s Commercial Activity Tax (CAT). The Ohio credit is designed to reward companies that specifically invest in physical R&D operations within the state’s borders.

Statutory Calculation and Commercial Activity Tax (CAT) Application

The Ohio R&D tax credit is calculated at a flat rate of 7% of the taxpayer’s excess qualified research expenses.

  • The Base Period Calculation: The base amount is calculated as the average annual qualified research expenses incurred by the taxpayer exclusively in Ohio over the three preceding taxable years. If a company is a startup and has insufficient history or no prior QREs in Ohio, the base is zero. This is a highly advantageous mechanism for new ventures relocating to or starting in Ohio, enabling a much higher percentage of their initial QREs to qualify as excess.
  • The Credit Computation: The final credit equals 7% multiplied by the difference between the Current Year Ohio QREs and the 3-Year Average Ohio QREs.
  • Application and Carryforward: The credit is applied against the Ohio Commercial Activity Tax (CAT), which is a tax imposed on the privilege of doing business in Ohio, measured by gross receipts. Because the R&D credit is nonrefundable, it can reduce the CAT liability to zero but cannot generate a cash refund from the state treasury. However, to protect the value of the investment, any unused portion of the credit may be carried forward for up to seven ensuing tax years.

Unlike the federal regular credit, which utilizes an antiquated gross receipts ratio to determine the base amount, Ohio strictly follows the Federal Alternative Simplified Calculation logic by focusing entirely on a three-year historical average of QREs, completely excluding gross receipts from the formula. Crucially, only research activities physically performed within the borders of Ohio qualify for this credit. Expenses based on activities incurred out-of-state must be completely excised from the federal QRE pool before calculating the Ohio base and current year amounts; they cannot be apportioned across states.

Transformative Legislative Changes: Ohio House Bill 33 (2024-2025)

Ohio House Bill 33 (HB 33), representing the state operating budget for fiscal years 2024-2025, introduced radical, systemic changes to the administration, calculation, and auditing of the Ohio R&D tax credit, fundamentally shifting the compliance landscape for corporate taxpayers operating in the state.

Pre-HB 33 Regulations (Prior to Jan 1, 2024) Post-HB 33 Regulations (Effective Jan 1, 2024) Strategic Impact on Taxpayers
Consolidated Group Calculation: Combined or affiliated corporate groups calculated the R&D credit across the entire taxpayer group on an aggregate basis. Member-by-Member Calculation: Taxpayer groups are now statutorily required to compute the R&D credit strictly on a member-by-member basis. The credit is allowed only for members who are formally part of the group on December 31 of the tax year. This change severely limits the ability of massive holding companies to utilize credits generated by highly innovative subsidiaries if the subsidiary itself lacks sufficient independent CAT liability to absorb the credit.
Standard Record Retention: General tax statute of limitations applied without specific, extended mandates for R&D documentation. Mandatory 4-Year Retention: Taxpayers are explicitly required by statute to maintain detailed records substantiating the calculation and eligibility of the credit for a minimum of four years. Elevates the administrative burden significantly; documentation must cleanly trace specific Ohio geographical locations for all claimed W-2 wages and supply invoices.
Audit Authority: The Ohio Department of Taxation (ODT) historically relied heavily on federal IRS determinations regarding Section 41 compliance, rarely challenging the underlying technological eligibility of the projects. Expanded Audit and Sampling Authority: The law explicitly empowers the ODT to audit a representative sample of a taxpayer’s R&D expenses and issue binding tax assessments based independently on their own interpretation of IRC Section 41. The ODT has adopted a highly aggressive posture, frequently challenging whether expenses meet the federal Section 41 definition, requiring robust, independent legal defense at the state level. Taxpayers often must escalate disputes to the Ohio Board of Tax Appeals (BTA).
CAT Thresholds: A $1 million gross receipt exclusion applied, alongside an annual minimum tax for all filers. Expanded Exclusion & Minimum Tax Elimination: The taxable gross receipt exclusion expands aggressively to $3 million in 2024 and $6 million in 2025. The annual minimum tax is entirely eliminated. Small to mid-sized innovators may have their CAT liability entirely wiped out by the exclusion. This shifts the R&D credit from an immediate cash-flow benefit into a pure carryforward asset reserved for future enterprise growth.

The intersection of the expanded CAT exclusion and the stringent member-by-member calculation means that businesses must engage in highly sophisticated tax planning. Furthermore, the aggressive audit posture adopted by the ODT has led to increased litigation before the Ohio Board of Tax Appeals (BTA). The BTA serves as the primary administrative tribunal for resolving disputes between taxpayers and the Tax Commissioner, and recent trends indicate that the ODT is demanding exhaustive, Suder-level documentation to prove that the activities physically occurring in Ohio meet the federal process of experimentation standard.

Cleveland’s Economic History and R&D Transformation

To fully comprehend how specific industries qualify for the R&D tax credit in Cleveland, it is necessary to examine the city’s profound historical economic evolution. Founded in 1796 by General Moses Cleaveland, the settlement remained a relatively isolated agricultural village for its first four decades. Manufacturing was limited to rudimentary craftsmen working in small shops to produce farming tools, barrels for salted meat, and milled flour.

The trajectory of Cleveland was permanently altered by the completion of the Ohio & Erie Canal in 1832, which connected Lake Erie to the Ohio River and transformed the city into a vital commercial transportation hub. The subsequent expansion of the railroad network in the 1850s granted the city unparalleled access to coal and oil from the south and east, and iron ore from the upper Great Lakes. This logistical supremacy ignited a massive industrial boom. The establishment of the Cuyahoga Steam Furnace Co. in 1827—which produced the first locomotive west of the Alleghenies—and the subsequent rise of massive steel operations like the Cleveland Rolling Mill Co. and Republic Steel positioned the city as a heavy manufacturing epicenter.

Concurrently, John D. Rockefeller founded the Standard Oil Co. in Cleveland in 1870, creating an insatiable demand for chemical processing and sulfuric acid, thereby birthing the region’s massive chemical industry. Innovators like Charles F. Brush pioneered electrical arc lighting in the 1870s, establishing the foundation for precision electrical engineering companies like the National Carbon Co. Furthermore, early automotive pioneers like Alexander Winton positioned Cleveland as an early rival to Detroit in automobile manufacturing. While Detroit eventually won the assembly-line war, Cleveland’s vast infrastructure pivoted toward precision parts manufacturing and machine tooling, becoming the mechanical backbone of the American industrial machine.

During the mid-to-late 20th century, aging infrastructure, union conflicts, and fierce foreign competition forced a painful period of deindustrialization upon the “Rust Belt.” However, Cleveland strategically and successfully pivoted its economy from traditional “smokestack” industries to advanced technology, healthcare, and advanced materials. Today, the region boasts world-renowned academic medical centers, massive federal aerospace research laboratories, and a burgeoning information technology sector. The deep-rooted metallurgical, chemical, and engineering expertise cultivated during Cleveland’s industrial boom provided the fundamental technical workforce necessary for today’s advanced manufacturers. This directly enables the localized R&D activities required to claim Ohio’s geographically restricted tax credits. The following five case studies illustrate how specific industries, deeply rooted in Cleveland’s history, execute modern R&D that is eligible for federal and state tax credits.

Case Study: Healthcare, Biotech, and Medical Devices

Historical Context and Development in Cleveland

Cleveland’s current global dominance in healthcare and bioscience is inextricably linked to the founding of the Cleveland Clinic in 1921. Following World War I, four visionary physicians returned to Cleveland and established a not-for-profit foundation modeled on a cooperative group practice. They dedicated the institution to integrating clinical expertise, medical education, and applied research, recognizing that medicine had become too complex for solitary practice. The Clinic pioneered numerous medical breakthroughs, notably expanding and perfecting cardiac surgery techniques in the early 1970s, establishing an international reputation.

Today, healthcare is a massive $22 billion industry in Northeast Ohio, serving as a primary driver of regional GDP and employment. To capitalize on this clinical density, the city strategically developed the “Health-Tech Corridor” (HTC) in the Midtown neighborhood, geographically linking the Cleveland Clinic, University Hospitals, and Case Western Reserve University. This 1,600-acre corridor now houses over 170 high-tech biomedical companies, major corporate research centers (such as Philips Healthcare’s global imaging R&D center), and numerous business incubators.

Crucially, Cleveland’s historical identity as a machining and metals hub has synergized with its medical prowess. As traditional aerospace and automotive applications stagnated, several old-line metal fabrication companies in Cleveland transitioned into producing highly specialized medical devices. They utilized their generational expertise in computer-controlled milling to fabricate orthopedic implants, surgical tools, and diagnostic hardware. Consequently, Ohio now boasts the second-largest number of FDA-registered medical device companies in the Midwest, heavily concentrated in the Cleveland area.

R&D Eligibility Example: AI-Enhanced Medical Imaging and Device Fabrication

The Scenario: A Cleveland-based medical technology firm located within the Health-Tech Corridor initiates an ambitious R&D project. The objective is to develop an artificial intelligence (AI) diagnostic algorithm that integrates with patient-specific, next-generation, 3D-printed titanium orthopedic joint replacements.

Federal and State R&D Credit Application:

  • Section 174 (Permitted Purpose): The firm faces profound technical uncertainty regarding whether their machine-learning algorithm can accurately predict joint wear-and-tear based on complex, patient-specific biomechanical imaging data. Furthermore, there is uncertainty regarding the optimal microscopic lattice structure of the 3D-printed titanium required to promote maximum osseointegration (bone ingrowth) without compromising the structural integrity of the implant.
  • Technological in Nature: The research relies fundamentally on computer science (AI algorithm development, neural networks), advanced materials science, and biomedical engineering.
  • Business Component: The final product is a new, proprietary medical device and an accompanying diagnostic software suite intended for commercial sale to hospital networks globally.
  • Process of Experimentation: The firm conducts extensive, iterative simulations. The software team evaluates various neural network architectures, adjusting hyperparameters to reduce false-positive wear predictions against a massive dataset of anonymized MRI scans. Simultaneously, the materials engineering team tests multiple 3D-printing metallurgical parameters—such as laser sintering speeds, focal points, and cooling rates—to forge prototype titanium joints. They evaluate these prototypes using cyclical stress-strain destructive testing to determine fatigue limits.
  • Federal Compliance: Following the precedent of the Suder case, the firm ensures that project managers maintain contemporaneous time-tracking software (e.g., Jira) to meticulously document the hours each developer and engineer spends specifically on technical problem-solving. The cost of the titanium powder consumed and destroyed during the destructive testing phases qualifies as supply QREs. Because the titanium implants were destroyed in testing and never sold to customers, they perfectly align with the eligibility principles established in Union Carbide.
  • Ohio State Considerations: Because the data scientists, biomedical engineers, and 3D-printing technicians are all physically located at the firm’s laboratory in the Cleveland Health-Tech Corridor, 100% of their W-2 wages qualify for the Ohio 7% R&D Investment Tax Credit. To comply with the stringent member-by-member requirements of Ohio HB 33, the firm carefully isolates the payroll of the specific corporate entity employing the engineers, ensuring no costs are inappropriately aggregated with out-of-state holding companies.

Case Study: Aerospace and Aviation Technologies

Historical Context and Development in Cleveland

Cleveland’s prominent role in the aerospace industry predates World War I. While the Wright brothers hailed from Dayton, Ohio, Cleveland rapidly became a center for the commercialization and mechanical advancement of aviation. In 1917, prominent local investors attracted the talented designer Glenn L. Martin to the city, establishing Cleveland’s first aircraft factory. The Glenn L. Martin Co. produced the highly successful Martin MB bomber and cultivated aviation legends like Donald Douglas and Lawrence Bell.

The city gained global aviation prominence by hosting the National Air Races from 1929 through the post-WWII era. These races were not merely entertainment; they served as a high-speed, dangerous proving ground for experimental aircraft engines and airframes. Cleveland’s immense precision manufacturing base easily adapted to the demands of aviation. Most notably, Thompson Products (which later became the conglomerate TRW) successfully modified complex automobile engine valve technology to withstand the extreme temperatures and pressures of aircraft engines, making the city a major producer of aviation parts.

The ultimate catalyst for Cleveland’s enduring aerospace R&D dominance was the 1940 decision by the National Advisory Committee for Aeronautics (NACA) to build its new Aircraft Engine Research Laboratory in Cleveland. Secured through intense local lobbying and the provision of discounted municipal electricity rates, this laboratory evolved into the NASA Glenn Research Center. Today, NASA Glenn features world-class testing facilities, including supersonic wind tunnels, zero-gravity drop towers, and massive thermal vacuum chambers. NASA Glenn contributes over $2 billion annually to Ohio’s economy and anchors a deep, highly specialized ecosystem of private aerospace contractors, defense manufacturers, and advanced materials researchers in the region.

R&D Eligibility Example: High-Speed Composite Flywheel Energy Storage

The Scenario: A Cleveland-based aerospace engineering firm, operating under a collaborative Small Business Innovation Research (SBIR) grant with NASA Glenn, undertakes the development of a revolutionary magnetically suspended composite rotor flywheel energy storage system. This system must be capable of operating at 60,000 RPM (mach 2.5 equivalent) for prolonged deep-space missions.

Federal and State R&D Credit Application:

  • Section 174 (Permitted Purpose): The engineering team faces significant technical uncertainty regarding the tensile strength of the carbon-fiber composite matrix when subjected to the extreme centrifugal forces at 60,000 RPM. There is also immense uncertainty regarding the design of the active magnetic bearings required to suspend the massive rotor in a vacuum without frictional degradation or catastrophic balance failure.
  • Technological in Nature: The activities rely strictly on aerospace engineering, electromagnetism, fluid dynamics, and advanced materials science.
  • Business Component: The prototype energy storage system is a new technological product being developed for integration into future commercial satellite platforms and defense contracts.
  • Process of Experimentation: The engineers utilize highly complex finite element analysis (FEA) software to simulate rotational stresses and thermal expansion on various composite weaves. Based on the modeling, they physically build multiple sub-scale prototypes, iteratively altering the epoxy resin curing process and tuning the magnetic levitation control algorithms. They subject these physical prototypes to dangerous spin-to-failure tests inside a reinforced vacuum chamber.
  • Federal Compliance: The rigorous, documented evaluation of different resin compounds and magnetic control algorithms perfectly satisfies the “process of experimentation” test as validated by the courts in Suder. The costs of the expensive carbon fiber, aerospace-grade epoxy resins, and the precision machining tooling destroyed during the spin-to-failure testing are fully eligible as supply QREs.
  • Ohio State Considerations: Given the stringent requirements of Ohio HB 33, the firm must meticulously track the location of its personnel. They must ensure that the specific engineers conducting the FEA and physically building the prototypes are W-2 employees of the Ohio entity on December 31 of the tax year. The firm must retain all testing logs, failure analyses, and payroll records for the mandatory four-year retention period to defend against the Ohio Department of Taxation’s expanded audit sampling authority, treating state compliance with the same rigor as an IRS examination.

Case Study: Polymer Science and Advanced Chemical Materials

Historical Context and Development in Cleveland

The chemical industry in Cleveland began as a series of small, homespun operations but expanded exponentially after the Civil War to supply John D. Rockefeller’s Standard Oil refineries with vast quantities of sulfuric acid. Eugene Ramiro Grasselli relocated his chemical works to Cleveland in 1867, establishing a massive industrial footprint that would eventually merge with Du Pont. Concurrently, paint and coatings pioneers like Sherwin-Williams (1870) and the Glidden Varnish Co. (1870) capitalized on the region’s rail network and the burgeoning automobile industry to build global empires. Mid-century firms like Harshaw Chemical Co. pioneered the development of scintillating crystals and refined uranium chemicals for the Manhattan Project.

As heavy metallurgical manufacturing waned in the late 20th century, Northeast Ohio leveraged its deep chemical legacy—alongside nearby Akron’s historical dominance as the “Rubber Capital of the World”—to pivot aggressively into the highly lucrative field of polymer science. The University of Akron established the College of Polymer Science and Polymer Engineering, recognized globally as a premier institution for macromolecular research.

To consolidate and accelerate this regional dominance, the State of Ohio recently launched the Greater Akron Polymer Innovation Hub. Supported by $31.25 million in state funding from the Ohio Innovation Hubs Program, this initiative unites major corporations like Goodyear, Bridgestone, and Synthomer to drive collaborative R&D in healthcare polymers, advanced mobility materials, electronics, and semiconductor materials. Furthermore, Cleveland-based giants like The Lubrizol Corporation continue to lead global markets in specialty chemicals, thermal management fluids, and advanced industrial additives.

R&D Eligibility Example: Immersion Cooling Thermal Fluids for AI Data Centers

The Scenario: A specialty chemical manufacturer headquartered in Cleveland initiates a massive R&D project to formulate a new class of dielectric thermal management fluids (conceptually similar to Lubrizol’s CompuZol) designed specifically for the direct liquid immersion cooling of high-density Artificial Intelligence data center servers.

Federal and State R&D Credit Application:

  • Section 174 (Permitted Purpose): The chemical engineers face intense uncertainty regarding the optimal molecular formulation. The fluid must provide maximum thermal conductivity to cool incredibly hot AI processors, while simultaneously maintaining absolute dielectric stability to prevent catastrophic electrical shorts. Furthermore, there is uncertainty regarding the long-term material compatibility of the fluid with the specific plastics and printed circuit boards used in the servers over a projected 10-year lifespan.
  • Technological in Nature: The project relies entirely on organic chemistry, thermodynamics, and fluid dynamics.
  • Business Component: The output is a new, proprietary chemical product (the immersion thermal fluid) intended for commercial sale to global data center operators.
  • Process of Experimentation: The research team designs a complex experimental matrix consisting of 50 different base synthetic oil and specialized additive combinations. They conduct accelerated thermal degradation testing, precisely measuring viscosity changes, specific heat capacity variations, and flash points at extreme temperatures. Crucially, they evaluate how different synthetic esters interact with standard server casing polymers through prolonged, heated immersion tests, systematically discarding formulations that cause plastic swelling, leaching, or brittleness.
  • Federal Compliance: The rigorous, documented batch testing and elimination of variables perfectly satisfies the scientific standard required by IRC Section 41.
  • Ohio State Considerations: Under Ohio’s R&D tax credit regulations, the salaries of the formulation chemists, laboratory technicians, and thermal engineers working in the Cleveland laboratory are fully eligible. The cost of the raw chemical precursors and the highly expensive, sacrificial server components that are destroyed or permanently altered during the prolonged immersion testing are eligible QRE supplies. To comply with the Ohio Department of Taxation’s aggressive audit stance (as noted in current tax literature), the company maintains rigorous, time-stamped laboratory notebooks and batch testing logs. This documentation is explicitly designed to definitively prove to state auditors that 80% or more of the activities constituted a true process of experimentation, satisfying the rigorous standards upheld in the Union Carbide decision.

Case Study: Smart Manufacturing and the Industrial Internet of Things (IIoT)

Historical Context and Development in Cleveland

Cleveland’s fundamental civic identity is deeply forged in the processing of iron and steel. The Cuyahoga Steam Furnace Co., established in 1827, produced the first locomotive west of the Alleghenies, inaugurating the city’s era of heavy industry. Following the Civil War, massive companies like the Cleveland Rolling Mill Co. and Republic Steel pioneered the large-scale production of Bessemer and open-hearth steel, supplying the nation’s infrastructural expansion. The city also dominated the highly technical machine-tool industry, with firms like Acme-Cleveland and Warner & Swasey providing the essential mechanical backbone for the Detroit automotive industry.

However, modern economic realities and globalization have forced Cleveland’s legacy manufacturers to evolve rapidly, embracing what is known as “Industry 4.0.” Advanced manufacturing in Northeast Ohio is no longer solely about brute force; it involves the sophisticated integration of the Industrial Internet of Things (IIoT), robotics, automation, and advanced metal alloys. By transforming traditional fabrication facilities into “smart factories,” local companies are using massive arrays of sensor data and machine learning to enable predictive maintenance, digital twin modeling, and precision computer numerical control (CNC) machining, ensuring they remain globally competitive.

R&D Eligibility Example: Digital Twin Simulation for Precision Metal Forming

The Scenario: A 75-year-old Cleveland-based metal forging company seeks to revolutionize its operations by developing a proprietary “Digital Twin” software system and integrating advanced IIoT sensors directly into its massive, multi-ton hydraulic forging presses. The goal is to predict microscopic metallurgical defects in real-time during the forging of highly stressed aerospace titanium components.

Federal and State R&D Credit Application:

  • Section 174 (Permitted Purpose): The mechanical engineers and software developers are deeply uncertain about which specific sensor configurations—vibration, acoustic emission, or high-speed thermal imaging—will yield telemetry data accurate enough to predict micro-fractures in titanium during the chaotic, high-impact stroke of a press. They are also uncertain about the appropriate architecture for the machine-learning algorithm required to process this high-velocity telemetry data in real-time.
  • Technological in Nature: The project relies on a synthesis of mechanical engineering, metallurgy, and computer science.
  • Business Component: The development of a new, highly advanced manufacturing process (the smart forging process) intended to drastically improve the quality, yield, and reliability of the company’s aerospace products.
  • Process of Experimentation: The firm retrofits a decommissioned test press with an array of experimental sensors. They forge hundreds of expensive titanium billets at varying temperatures and pressures, feeding the continuous sensor data into their prototype digital twin software. They meticulously cross-reference the software’s real-time defect predictions with post-forging, destructive ultrasonic scans of the actual billets. The software code is iteratively refined over months to eliminate mechanical signal noise and improve prediction accuracy.
  • Federal Compliance: The titanium billets forged specifically to train the AI model—which are subsequently scrapped and not sold to aerospace customers due to their experimental nature—qualify fully as supply QREs. Because they are not utilized in normal production, they avoid the disallowance precedent set by the Union Carbide decision.
  • Ohio State Considerations: Under the strict parameters of the Ohio CAT R&D credit post-HB 33, if this manufacturing company is a subsidiary of a larger, multi-state industrial holding group, the credit must be calculated specifically for the individual corporate member incurring these expenses in Ohio. The wages of the mechanical engineers and software developers who install the sensors and write the algorithm are eligible. The company must retain all testing logs for four years, preparing for the possibility that the Ohio Department of Taxation may audit a representative sample of these massive supply expenses.

Case Study: Information Technology and Financial/Healthcare Software

Historical Context and Development in Cleveland

While historically renowned for the production of physical goods, Cleveland has experienced a dramatic and rapid surge in the technology, cybersecurity, and software sectors. The city is currently ranked among the top 10 fastest-growing markets for tech talent in the United States, experiencing an impressive 5.8% tech job growth since 2018. Cleveland is the headquarters for major national financial institutions like KeyBank and the Federal Reserve Bank of Cleveland, operating alongside major software developers such as Hyland Software and OverDrive.

This modern tech boom is heavily synthesized with the city’s massive healthcare infrastructure. Hospital systems like the Cleveland Clinic are aggressively deploying advanced Artificial Intelligence not just in diagnostics, but to streamline the massive bureaucratic backend of healthcare operations. They utilize predictive software to manage hospital transfer admissions via Virtual Command Centers and optimize financial routing. This unique intersection of Financial Technology (FinTech), HealthTech, and enterprise software has created a highly fertile ecosystem for specialized software development R&D in Northeast Ohio.

R&D Eligibility Example: AI-Driven Healthcare Revenue Cycle Management Software

The Scenario: A Cleveland-based software development firm specializing in the intersection of FinTech and HealthTech initiates the development of a highly proprietary, AI-driven Revenue Cycle Management (RCM) platform. The software aims to utilize advanced Natural Language Processing (NLP) to read unstructured physician notes, automatically assign complex medical billing codes, and route the claims through a secure, distributed blockchain-based ledger to instantly verify insurance pre-authorizations, thereby drastically reducing claim denial rates for hospital networks.

Federal and State R&D Credit Application:

  • Section 174 (Permitted Purpose): The software architects face intense technical uncertainty regarding how to build an NLP algorithm capable of accurately interpreting highly variable, unstructured medical jargon and physician shorthand with the required 99% accuracy rate. Furthermore, there is systemic uncertainty regarding the integration of a decentralized blockchain ledger with the legacy, high-latency mainframe systems used by major insurance carriers, without causing catastrophic timeout errors.
  • Technological in Nature: The project relies purely on computer science, specifically cryptography, artificial intelligence, and complex database architecture.
  • Business Component: The development of new commercial software intended for licensing to national hospital networks. (Note: If the software were developed solely for the firm’s internal administrative use, it would have to meet the much stricter “High Threshold of Innovation” test for Internal-Use Software. However, because it is held for commercial license, the standard Four-Part Test applies).
  • Process of Experimentation: The software team operates using an iterative Agile methodology. They evaluate various open-source NLP libraries, testing them against a massive “sandbox” dataset of anonymized medical records. They rigorously measure processing speed, memory leak occurrences, and coding accuracy rates. They iterate the code, write custom machine-learning weightings, and perform aggressive load-testing on the blockchain routing mechanism to evaluate system latency under simulated peak transactional loads.
  • Federal Compliance: Following the vital precedent of the Suder case, the firm ensures that project managers maintain contemporaneous time-tracking software (e.g., Jira or Asana) to meticulously document the hours each developer spends specifically on technical problem-solving. Because cloud computing is critical for compiling and stress-testing this software, the firm can claim the costs of renting secure AWS or Azure server space specifically utilized for the testing environment (cloud computing expenses qualify under IRC Section 41).
  • Ohio State Considerations: The firm claims the W-2 wages of the software engineers, data scientists, and QA testers physically located in their Cleveland offices. With the expansion of the CAT exclusion to $6 million in 2025 under HB 33, this rapidly growing software firm may find its actual tax liability wiped out. However, by meticulously calculating the 7% credit on a member-by-member basis and maintaining the strict 4-year documentation standard required to satisfy an ODT audit, the firm can bank these substantial R&D credits as carryforwards, creating a massive financial asset to offset future tax liabilities as the company scales.

Strategic Compliance and Future Outlook

The landscape of R&D tax credits in Cleveland, Ohio, represents a highly lucrative but increasingly perilous terrain of regulatory complexity. The convergence of strict federal IRS scrutiny—particularly regarding the substantiation of employee wages and the definition of a process of experimentation, as adjudicated in the Moore, Suder, and Union Carbide cases—and the newly aggressive posture of the Ohio Department of Taxation demands a paradigm shift. Taxpayers can no longer treat R&D credit calculation as a mere retrospective accounting function; it must be managed proactively as a rigorous legal and engineering compliance exercise.

Navigating Ohio HB 33 and Audit Preparedness

The enactment of Ohio House Bill 33 has fundamentally altered the mechanics of the state R&D credit. By forcing affiliated corporate groups to calculate credits on a strict member-by-member basis, the state has eliminated the ability of diversified holding companies to easily offset profitable entities’ CAT liabilities with the innovative expenditures of their pre-revenue R&D subsidiaries.

Furthermore, the explicit statutory authorization for the ODT to sample R&D expenses and directly audit IRC Section 41 compliance means that Cleveland businesses must maintain “audit-ready” documentation at all times, facing the genuine threat of litigation before the Ohio Board of Tax Appeals. The required four-year record retention mandate dictates that companies must continuously archive contemporaneous time tracking, detailed technical documentation (laboratory notebooks, CAD drawings, Git code commits, failure logs), and payroll records that definitively prove the claimed expenditures occurred physically within the state of Ohio.

Cleveland’s Sustained Innovation Trajectory

Despite this regulatory tightening, Cleveland remains uniquely positioned to leverage these financial incentives to fuel its ongoing economic transformation. The city’s strategic, coordinated investments in the Health-Tech Corridor, the Greater Akron Polymer Innovation Hub, and the continued, robust operational presence of the NASA Glenn Research Center provide an unmatched geographical infrastructure for advanced R&D. As legacy manufacturers continue to adopt IIoT and smart manufacturing technologies to survive in a hyper-competitive global market, the volume of eligible R&D activities in Northeast Ohio is projected to expand significantly.

By strictly adhering to the federal Four-Part Test, understanding the boundaries established by monumental case law, and adapting to the new member-by-member calculations dictated by Ohio HB 33, Cleveland businesses across the healthcare, aerospace, polymer, manufacturing, and information technology sectors can safely secure the vital capital necessary to fund their next generation of technological breakthroughs.

Final Thoughts

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.

R&D Tax Credits for Cleveland, Ohio Businesses

Cleveland, Ohio, thrives in industries such as healthcare, manufacturing, education, finance, and technology. Top companies in the city include the Cleveland Clinic, a leading healthcare provider; Sherwin-Williams, a major manufacturing employer; Case Western Reserve University, a significant educational institution; KeyBank, a key player in the finance sector; and Progressive Insurance, a prominent technology company. The R&D Tax Credit can provide tax savings for these industries by incentivizing innovation and technological advancements.

Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

directive for LBI taxpayers

Pass an Audit?

directive for LBI taxpayers

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 20 E Broad St, Columbus, Ohio is less than 145 miles away from Cleveland and provides R&D tax credit consulting and advisory services to Cleveland and the surrounding areas such as: Akron, Parma, Lorain, Elyria and Lakewood.

If you have any questions or need further assistance, please call or email our local Ohio Partner on (380) 220-1380.
Feel free to book a quick teleconference with one of our Ohio R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.



Cleveland, Ohio Patent of the Year – 2024/2025

Cleveland Medical Devices Inc. has been awarded the 2024/2025 Patent of the Year for revolutionizing sleep health technology. Their invention, detailed in U.S. Patent No. 11857333, titled ‘Integrated sleep diagnostic and therapeutic system and method’, combines sleep monitoring and treatment in a single, streamlined device.

This new system offers a comprehensive way to diagnose and treat sleep disorders with ease. It integrates advanced sensors and therapeutic functions to track sleep patterns and deliver timely interventions. The technology targets common conditions like sleep apnea, improving patient outcomes while reducing the need for multiple devices.

Cleveland Medical Devices Inc. designed this system for user comfort and clinical efficiency. Patients can receive real-time treatment based on accurate, continuous monitoring data. This approach reduces delays in diagnosis and shortens treatment timelines.

The device’s smart algorithms analyze sleep quality and automatically adjust therapy. This personalized care promotes better sleep and overall health. The invention could transform how sleep disorders are managed in homes and clinics.

By uniting diagnosis and therapy, Cleveland Medical Devices Inc. advances sleep medicine into a new era. Their innovation promises to improve lives by making sleep health more accessible, effective, and patient-friendly.


R&D Tax Credit Training for OH CPAs

directive for LBI taxpayers

Upcoming Webinar

 

R&D Tax Credit Training for OH CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinar

 

R&D Tax Credit Training for OH SMBs

water tech

Upcoming Webinar

 


Choose your state

find-us-map

Never miss a deadline again

directive for LBI taxpayers

Stay up to date on IRS processes

Discover R&D in your industry

Contact Us


Ohio Office 

Swanson Reed | Specialist R&D Tax Advisors
20 E Broad St
Columbus, OH 43215

Phone: (380) 220-1380

Contact Us

Send us a message and we will be in touch shortly!

Start typing and press Enter to search